SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?


To: Arthur Radley who wrote (7)3/3/1998 11:11:00 PM
From: bluejeans  Read Replies (1) | Respond to of 626
 
Hello Texas Dude,

(1)Just why do you think I am tired of talking to myself? ;)

(2)You should put the link to this thread in the Ligand thread for those threadsters that are not only paranoid, but also incapable of doing anything for themselves (would that make them co dependents ?):)

I have bookmarked the thread . Do you have plans to make the hot subject list?

P.S. they really are out to get you;aren't they?<G>



To: Arthur Radley who wrote (7)3/3/1998 11:57:00 PM
From: Abuckatatime  Read Replies (1) | Respond to of 626
 
TD, have you got much from the company that isn't on the web? What info do you have regarding the cancer immunotherapeutics, CeaVac, TriGem, and TriAB which were expected to be in PII/IIIs early this year? The potential for improved anti-Parkinson agents could be huge, but Spheramine is still in preclinicals, right? Regarding iloperidone, the drug Novartis is backing (thank you very much), have you seen any of the early clinical data? A quick Medline search turned up articles on the pharmacology (5HT and dopamine receptor binding affinities etc.) and some behavioral data from rats but little/nothing on human behavioral data. Or did I miss something? I apologize for all the questions, but hey, you're the man who got this ball rolling! I've just glanced at the financials, may need to see 10k before jumping to conclusions regarding company's financial strength and need for additional funding. Finally, what do you know about management? Usually a tough one to get a grip on.

thanks in advance